Table 1.
Clinicopathological characteristics of breast cancer patients
| Baseline Characteristics | Progressors | Non-progressors |
|---|---|---|
| Patient Age, n (%) | ||
| 30–39 | 3 (13.6) | 2 (6.8) |
| 40–49 | 3(13.6) | 9 (31.0) |
| 50–59 | 7 (31.8) | 8 (27.5) |
| 60–69 | 5 (22.7) | 8 (27.5) |
| 70+ | 4 (18.1) | 2 (6.8) |
| Tumor Grade, n (%) | ||
| I | 3 (13.6) | 3 (10.3) |
| II | 3 (13.6) | 8 (27.5) |
| III | 15 (68.1) | 17 (58.6) |
| Missing | 1 (4.5) | 1 (3.4) |
| Receptor status, n (%) | ||
| ER/PR/HER2-positive | 2 (9.0) | 5 (17.2) |
| HER2-positive | 3 (13.6) | 3 (10.3) |
| ER/PR-positive & HER2-negative | 6 (27.2) | 12 (41.3) |
| TNBC | 6 (27.2) | 6 (20.6) |
| Others | 5 (22.7) | 3 (10.3) |
| LN status, n (%) | ||
| Positive | 14 (63.6) | 12 (41.3) |
| Negative | 8 (36.3) | 16 (55.1) |
| Missing | 0 (0.0) | 1 (3.4) |
| Survival Status, n (%) | ||
| Alive | 11 (50.0) | 29 (100.0) |
| Dead | 11 (50.0) | 0 (0.0) |